Paid Clinical Trials Wilmington

Discover 258 paid clinical trials in Wilmington, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 258

Saruparib

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Newark DE, Bala-Cynwyd PA, Philadelphia PA, Camden NJshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Epcoritamab & Anti-Neoplastics

Recruiting

PHASE2

Sponsor:

Genmab

Location:

Newark DE, Philadelphia PA, Baltimore MD, New York NYshow 13 more

Code:

NCT05283720

Conditions

Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Lenalidomide

Ibrutinib

Rituximab

Cyclophosphamide

Petosemtamab vs. Pembrolizumab

Recruiting

PHASE3

Sponsor:

Merus N.V.

Location:

Newark DE, Philadelphia PA, Norfolk VA, Blacksburg VAshow 16 more

Code:

NCT06525220

Conditions

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Petosemtamab

Pembrolizumab

L-Arginine

Recruiting

Sponsor:

The University of Texas at Arlington

Location:

Newark DE, Dallas TX

Code:

NCT03982160

Conditions

Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

L-Arginine

Placebo

Observational Study

Recruiting

Sponsor:

National Cancer Institute (NCI)

Location:

Wilmington DE, Newark DE, Baltimore MD, New York NYshow 94 more

Code:

NCT02474160

Conditions

Hematopoietic and Lymphatic System Neoplasm

Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Amivantamab-Subcutaneous

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Dover DE, Ephrata PA, Milford DE, Lebanon PAshow 85 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Surgery vs. Treatment

Recruiting

PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Wilmington DE, Chadds Ford PA, Newark DE, Elkton MDshow 11 more

Code:

NCT06632327

Conditions

Resectable Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Stage IIIB Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Procedure

Cisplatin

Carboplatin

Pemetrexed

Gemcitabine

MILD

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Newark DE, Elkton MD, Havre De Grace MD, Bel Air MDshow 1071 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Bupropion

Recruiting

PHASE3

Sponsor:

University of Rochester NCORP Research Base

Location:

Wilmington DE, Chadds Ford PA, Newark DE, Allentown PAshow 290 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

Immunotherapy

Recruiting

PHASE2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Wilmington DE, Chadds Ford PA, Newark DE, Elkton MDshow 65 more

Code:

NCT05647265

Conditions

Pleural Biphasic Mesothelioma

Pleural Sarcomatoid Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Ipilimumab

Surgical Procedure

Computed Tomography

Magnetic Resonance Imaging